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Abstract 
Background: Formation of inclusion bodies poses a major hurdle in recovery of bioactive recombinant protein from 
Escherichia coli. Urea and guanidine hydrochloride have routinely been used to solubilize inclusion body proteins, but 
many times result in poor recovery of bioactive protein. High pH buffers, detergents and organic solvents like n-pro-
panol have been successfully used as mild solubilization agents for high throughput recovery of bioactive protein 
from bacterial inclusion bodies. These mild solubilization agents preserve native-like secondary structures of proteins 
in inclusion body aggregates and result in improved recovery of bioactive protein as compared to conventional solu-
bilization agents. Here we demonstrate solubilization of human growth hormone inclusion body aggregates using 
30 % trifluoroethanol in presence of 3 M urea and its refolding into bioactive form.
Results: Human growth hormone was expressed in E. coli M15 (pREP) cells in the form of inclusion bodies. Different 
concentrations of trifluoroethanol with or without addition of low concentration (3 M) of urea were used for solu-
bilization of inclusion body aggregates. Thirty percent trifluoroethanol in combination with 3 M urea was found to 
be suitable for efficient solubilization of human growth hormone inclusion bodies. Solubilized protein was refolded 
by dilution and purified by anion exchange and size exclusion chromatography. Purified protein was analyzed for 
secondary and tertiary structure using different spectroscopic tools and was found to be bioactive by cell proliferation 
assay. To understand the mechanism of action of trifluoroethanol, secondary and tertiary structure of human growth 
hormone in trifluoroethanol was compared to that in presence of other denaturants like urea and guanidine hydro-
chloride. Trifluoroethanol was found to be stabilizing the secondary structure and destabilizing the tertiary structure 
of protein. Finally, it was observed that trifluoroethanol can be used to solubilize inclusion bodies of a number of 
proteins.
Conclusions: Trifluoroethanol was found to be a suitable mild solubilization agent for bacterial inclusion bodies. Fully 
functional, bioactive human growth hormone was recovered in high yield from inclusion bodies using trifluoroetha-
nol based solubilization buffer. It was also observed that trifluoroethanol has potential to solubilize inclusion bodies of 
different proteins.
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Background
Escherichia coli has been the host microorganism of 
choice for production of recombinant proteins due to 
a variety of reasons, the most important reasons being 
the extensive knowledge available on its physiology, ease 
of genetic manipulations and faster growth rate in con-
trolled environment [1, 2]. Many times, overproduction 
of the target protein in E. coli leads to their accumulation 
in the form of aggregates called inclusion bodies (IBs). 
The major cause for formation of IBs is the high trans-
lational rate that keeps the protein concentration high 
inside the cytosol and allows the partially folded protein 
molecules to interact with each other to form aggregates 
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[3, 4]. Most protocols for protein recovery from IBs 
include solubilization using a denaturing agent followed 
by refolding of solubilized protein and subsequent purifi-
cation of the refolded protein [5, 6]. The formation of IBs 
is a boon in the way that it decreases the number of steps 
for protein purification, as IBs consist mostly of a single 
protein of interest due to the specific feature of protein 
aggregation [7, 8]. But at the same time, one cannot guar-
antee recovery of bioactive protein after solubilization 
and refolding procedures. This stresses on the need for 
development of new solubilization and refolding meth-
ods to improve the chances of recovery of bioactive pro-
tein from IBs.
Classically IBs were considered as aggregates with no 
biological activity. But recent advances have shown that 
IBs may contain some proportion of bioactive protein 
molecules [9, 10]. Recovery of active protein from such 
IBs relies on use of non-denaturing solubilization agents 
without the need of the refolding step. Some of the exam-
ples of non-denaturing solubilization agents include 
N-lauroyl sarcosine, dimethysulfoxide (DMSO) and low 
percentage (5 %) of n-propanol [9]. The yield depends on 
the proportion of properly folded active protein molecules 
present in IBs, which in turn depends on the expression 
conditions. Another method of recovering protein from 
IBs makes use of mild solubilization agents which pre-
serve the existing native-like secondary structures in the 
solubilized state. Examples include solubilization using 
high pH buffers, detergents, low denaturant concentration 
and use of 6  M n-propanol [9–15]. Solubilization using 
mild agents help in improving the yield of bioactive pro-
tein as it helps in decreasing aggregation during refold-
ing [16]. The possible reason for increased refolding yield 
comes from the fact that mild solubilization preserves the 
existing native-like secondary structure of protein mol-
ecules. If the secondary structures are on the refolding 
pathway, the chances of protein getting into aggregation 
pathway decrease. On the other hand if protein molecules 
get completely unfolded, the chances of accessing the 
aggregation pathway during refolding increase and results 
in low recovery of bioactive protein [14].
Human growth hormone (hGH) has been success-
fully recovered in bioactive form from IBs [14, 16–18]. 
hGH IBs require high concentration (6–8 M) of urea for 
solubilization. Guanidine hydrochloride (GdnHCl) is 
also an effective solubilization agent but refolding from 
GdnHCl denatured state leads to considerable aggre-
gation and result in low recovery of bioactive protein. 
Even from the urea denatured state the yield at refold-
ing step is about 50 % and overall recovery is 21 % [18]. 
Mild solubilization strategies have been shown to be 
effective for recovery of hGH from IBs. High pH buffer 
and n-propanol based buffer with 2  M urea have been 
described as mild solubilization agents for solubili-
zation of hGH IBs with a high yield at refolding stage 
(about 70 %) [14, 16–18]. High refolding yield obtained 
in these cases was expected because of preservation of 
native-like secondary structures of protein in the solu-
bilized state.
The effect of organic solvents on protein structure 
has long been studied [19, 20]. In general, alcohols like 
methanol, ethanol and trifluoroethanol (TFE) are known 
to stabilize secondary structure, mainly helical structure. 
The effect of organic solvents on the tertiary structure 
is more generalized and most of the solvents destabilize 
the tertiary structure [21–23]. Organic solvents affect the 
secondary and tertiary structure of proteins by increas-
ing the polypeptide intramolecular hydrogen bonding, 
disrupting the hydrophobic interactions or by interact-
ing with water molecules and influencing their hydrogen 
bonding potential [22].
Here we describe TFE as solubilization agent and estab-
lish its usefulness by showing recovery of bioactive hGH 
from IBs. Purified hGH was characterized using bio-
physical tools and cell proliferation assay. To understand 
the mechanism of inclusion body solubilization by TFE, 
secondary and tertiary structure of hGH in presence of 
TFE was investigated and compared to that in presence 
of other solubilization agents like urea and GdnHCl. It 
was also observed that solubilization of IBs with TFE is 
a widespread phenomenon and can be applied to many 
other proteins.
Results and discussion
Expression of recombinant hGH and IB preparation
Recombinant hGH was expressed as 22  kDa protein in 
E. coli. About 30 % of the total cellular protein was hGH. 
Majority of the expressed protein was in the form of IBs. 
IBs were isolated by sonication followed by centrifuga-
tion. About 80 mg of IBs were obtained per liter of bac-
terial culture. The purity of hGH IBs was assessed by 
SDS-PAGE and was found to be around 90 % (Fig. 1).
Solubilization and refolding of inclusion body protein
The solubilization potential of TFE containing buffers 
was compared to those containing TFE in combination 
with 3 M urea (Fig. 2). Low concentration of urea (3 M) 
alone did not bring about appreciable solubilization of 
hGH IBs. TFE by itself is not a very potent solubiliza-
tion agent and did not bring out complete solubilization 
of hGH IBs even at 50 % concentration. But use of 3 M 
urea with buffers containing TFE improved their solu-
bilization potential and decreased the requirement of 
TFE. Complete solubilization of hGH IBs was achieved 
in buffer containing 30  % TFE in presence of 3  M urea 
(Fig. 2).
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hGH IBs obtained from 1 l of bacterial culture were sol-
ubilized in buffer containing 50 mM Tris–HCl, 30 % TFE, 
3  M urea and 1  mM DTT. For comparison of refolding 
yield, IBs obtained from 1 l of bacterial culture were also 
solubilized in buffer containing 50  mM Tris–HCl, pH 
12, 2 M urea and 1 mM DTT (Table 1). The refolding of 
solubilized protein obtained by two methods was carried 
out under identical conditions, using the same refold-
ing buffer. The refolding yield was calculated for both 
the conditions and it was observed that a higher yield is 
obtained when TFE based buffer is used as solubiliza-
tion agent as compared to high pH buffer with 2 M urea 
(Table  1). About 45  % of recombinant hGH was recov-
ered from IBs using TFE as solubilization agent (Table 2). 
The reason for the high refolding yield in case of TFE 
based solubilization could stem from partial stabilization 
of protein secondary structures in the solubilized state.
Purification of hGH
Refolded hGH obtained after solubilization in TFE 
based buffer was purified using anion exchange chro-
matography followed by size exclusion chromatography 
(SEC) (Fig.  3a, b). Recombinant hGH with purity lev-
els more than 95  % was obtained by chromatographic 
methods. About 36 mg of pure hGH could be recovered 
from 79 mg IBs when TFE based solubilization was used 
(Table 2). The purity of hGH obtained after each round of 
purification was compared using SDS-PAGE (Fig. 3c, d).
Earlier attempts at purifying hGH from IBs using mild 
solubilization agents involved use of high pH buffer and 
n-propanol based buffer with 2 M urea [14, 16–18]. 8 M 
urea or 6 M GdnHCl have also been used as solubilization 
agents. A comparative study showing overall recovery 
of bioactive hGH from IBs using different solubiliza-
tion agents has been shown in Table 3. Overall recovery 




















Fig. 1 SDS-PAGE analyses of r-human growth hormone expression 
and IB purification. a Expression of r-human growth hormone. Lane 1 
uninduced cell lysate, lane 2 induced cell lysate, lane M LMW marker 
(97, 66, 45, 30 and 20.1 kDa). b Isolation of IBs. Lane 1 purified IBs, lane 
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Fig. 2 Solubilization of hGH IBs in different concentrations of TFE in presence or absence of 3 M urea. a SDS-PAGE analysis of hGH IB solubiliza-
tion. Lane 1–4 supernatant of hGH IBs solubilized in TFE concentrations ranging from 20 to 50 %, lane 5–8 supernatant of hGH IBs solubilized in TFE 
concentrations ranging from 10 to 40 % along with 3 M urea, lane 9 supernatant of hGH IBs solubilized in 3 M urea, lane 10 supernatant of hGH IBs 
solubilized in 8 M urea, lane M LMW marker (97, 66, 45, 30, 20.1, 14.4 kDa). b Turbidimetry of hGH IBs solubilized in different concentrations of TFE in 
absence and presence of 3 M urea at 380 nm
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Refolding yield obtained with mild solubilization meth-
ods is generally higher than that obtained with 8 M urea 
and 6 M GdnHCl. Bioactivity of the hGH refolded from 
IBs solubilized with mild solubilization agents were more 
or less similar. The improved refolding yield reflects on 
the overall recovery and high amount of bioactive protein 
could be recovered using mild solubilization methods.
Characterization of purified protein
Purified hGH was characterized using different spectro-
scopic techniques. hGH obtained from IBs using high pH 
solubilization followed by refolding and purification was 
used as positive control. It has been shown previously 
that bioactive hGH can be recovered from IBs using high 
pH solubilization buffer containing 2 M urea [17, 18, 24]. 
Secondary structure of purified hGH as determined by 
far UV CD spectroscopy is shown in Fig.  4a. hGH is a 
completely α-helical protein with eight helices. Purified 
hGH showed negative bands at 208 and 222 nm, charac-
teristic of α-helical proteins. The CD spectrum obtained 
was similar to that reported earlier for recombinant hGH 
obtained after solubilization in high pH buffer as well as 
native hGH [17, 18]. This also emphasizes that refolded 
protein obtained after solubilization in TFE based buffer 
was properly folded and have α-helical structures.
Tertiary structure of refolded hGH was analyzed by 
near UV CD (Fig.  4b) and fluorescence spectroscopy 
(Fig.  4c). Near UV CD spectra of purified hGH showed 
a positive band with peak at 292 nm and a negative band 
with peak at 280 nm, which suggests the formation of ter-
tiary contacts around tryptophan and tyrosine residues 
respectively, emphasizing formation of proper confor-
mations during refolding procedure. hGH purified after 
solubilization in high pH buffer also showed similar spec-
trum. Near UV CD spectra of two purified protein prepa-
rations were also similar to that of native hGH reported 
earlier [24]. Intrinsic tryptophan fluorescence spectra of 
two hGH preparations were comparable to each other 
and to that of native hGH [24]. hGH contains eight tyros-
ine residues and single tryptophan residue. To assess 
proper folding of hGH, protein samples were excited at 
280 nm, at which both tryptophan and tyrosine absorb. 
Emission spectrum of tyrosine is blue shifted in compari-
son to that of tryptophan. Figure 4c shows fluorescence 
emission spectra of hGH with maxima at 337  nm. This 
suggested the presence of tryptophan residue buried 
in the hydrophobic core as exposed tryptophan shows 
maxima at higher wavelength. Also there is no contribu-
tion from tyrosine emission due to energy transfer from 
tyrosine to tryptophan in compactly folded protein. This 
suggests compact and properly folded structure of puri-
fied hGH obtained from IBs using TFE as solubilization 
agent.
Bioactivity of purified hGH
Bioactivity of hGH was assessed using proliferation of 
Nb2 cell line. Nb2 cells are rat lymphoma dependent on 
prolactin for proliferation. It has prolactin receptors on 
cell surface that internalizes on prolactin binding and 
induces mitogenesis. hGH binding to prolactin receptor 
also induces cell proliferation [25]. Increase in cell num-
ber can thus be used as an assay for bioactivity of hGH. 
Figure  4d shows bioactivity of purified hGH. Commer-
cial hGH (Boehringer Mannheim, Germany) was used as 
positive control. Untreated cells and cells treated with an 
unrelated protein ovalbumin are also taken as negative 
controls. Purified hGH showed comparable proliferation 
of cells at a concentration of 5 ng/ml and the proliferation 
was significantly higher than in control groups (p < 0.05). 
This proves that hGH recovered from IBs using TFE 
based solubilization was fully functional and biologically 
active.
Solubilization of different IB proteins using TFE
To establish the effectiveness of TFE as solubili-
zation agent, IBs of nine different proteins (hGH, 
Table 1 Comparative analysis of solubilization efficiency and refolding yield of hGH from IBs while using high pH or TFE 
based buffer for solubilization








High pH buffer with 2 M urea and 1 mM DTT 62.99 ± 3.92 34.45 ± 2.2 79.63 ± 4.96 54.89 ± 5.9
30 % TFE with 3 M urea and 1 mM DTT 71.78 ± 2.94 61.43 ± 2.97 90.75 ± 3.72 85.59 ± 2.46
Table 2 Purification of  hGH from  inclusion bodies using 
TFE as solubilization agent
Details of protein yield at each step of purification and step yield indicate the 
suitability of this current method for high recovery of protein from inclusion 
bodies of E. coli
Sample Amount (mg) Step yield (%) Overall yield (%)
IBs 79.14 – –
Solubilized protein 74.21 94 94
Refolded protein 64.83 87 82
DEAE purified  
protein
46.8 72 59
SEC purified protein 35.6 76 45
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enolase, asparaginase, polyketide synthase, aldolase, 
ovalbumin, superoxide dismutase, ovine growth hor-
mone and lysozyme) were solubilized using TFE. Protein 
concentrations of all nine IB proteins were kept constant 
(40–50  mg/ml) and solubilized in fixed concentration 
of TFE (50  %) without addition of urea. Some of the 
IBs included in this study are soft IBs, i.e. they get solu-
bilized in low concentration of urea (3  M). To keep the 
conditions of solubilization constant, all IBs were solu-
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Fig. 3 Purification of r-hGH. a FPLC chromatogram of r-hGH purification by DEAE-Sepharose ion-exchange chromatography. Blue line UV absorb-
ance at 280 nm, brown line conductance. b FPLC chromatogram of r-hGH purification by size exclusion chromatography. c SDS-PAGE analysis 
of purified protein pooled after DEAE-Sepharose ion exchange chromatography. Lane 1 purified r-hGH, lane M LMW marker (97, 66, 45, 30 and 
20.1 kDa). d SDS-PAGE analysis of purified protein pooled after size exclusion chromatography. Lane 1 purified r-hGH, lane M LMW marker (97, 66, 45, 
30 and 20.1 kDa)
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without urea. IBs of nine different proteins are presented 
in Fig. 5a. Supernatants of solubilized IBs were analyzed 
by SDS-PAGE and presented in Fig. 5b. Except aldolase, 
ovalbumin and lysozyme IBs, other IBs were efficiently 
solubilized using TFE. This indicated that TFE can be 
used to solubilize IB aggregates of many proteins.
Structural analysis of solubilized hGH
To understand the mechanism of solubilization by TFE, 
its effect on secondary and tertiary structure of hGH was 
investigated and compared with other solubilization agents 
like urea and GdnHCl. The effect of different solubilization 
agents on secondary structure of hGH was studied using 
far UV CD spectroscopy and that on tertiary structure of 
hGH was investigated by SEC and intrinsic tryptophan 
fluorescence. Fluorescence spectra of hGH incubated in 
different buffers were also compared to fluorescence spec-
tra of tryptophan analogue, N-acetyl-l-tryptophanamide 
(NATA) in respective buffers. Acrylamide quenching was 
also used as a tool to measure tryptophan accessibility of 
hGH in presence of different solubilization buffers.
Table 3 Comparison of  different solubilization agents 
for recovery of hGH from IBs





50 mM Tris, pH 8.5, 8 M  
urea
50 21 [14, 18]
50 mM Tris, pH 12, 2 M urea 86 42 [17, this study]
50 mM Tris, pH 8.5, 6 M 
n-propanol, 2 M urea
76 40 [14]
50 mM Tris, pH 8.5, 30 %  
TFE, 3 M urea
87 45 This study
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Fig. 4 Biophysical characterization of r-hGH. a Far UV CD spectra of r-hGH purified after solubilization in TFE based buffer along with that of hGH 
purified after solubilization in high pH buffer containing 2 M urea. b Near UV CD spectra of r-hGH purified after solubilization in TFE based buffer 
along with that of hGH purified after solubilization in high pH buffer containing 2 M urea. c Fluorescence spectra of r-hGH purified after solubiliza-
tion in TFE based buffer along with that of hGH purified after solubilization in high pH buffer containing 2 M urea. d Nb2 cell proliferation assay of 
r-hGH purified after solubilization in TFE based buffer along with that of commercial hGH. Ovalbumin (ova) was used as negative control
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Far UV CD spectroscopy of solubilized hGH
Secondary structure of hGH in presence of different sol-
ubilization buffers  (Table  4) was investigated by far UV 
CD spectroscopy and is presented in  Fig.  6a, b. hGH is 
a completely α-helical protein with eight helices. Its far 
UV CD spectrum is characterized by negative bands at 
208 and 222 nm. Figure  6a shows the effect of different 
concentrations of TFE on secondary structure of hGH 
and compares it with that observed with 8  M urea or 
6  M GdnHCl. Similarly Fig.  6b shows the effect of dif-
ferent concentrations of TFE in combination with 3  M 
urea on hGH secondary structure. It was observed that 
increasing concentrations of TFE had a stabilizing effect 
on secondary structure of hGH. At concentrations above 
25  % of TFE, there was an increase in ellipticity at 208 
and 222 nm indicating stabilization of α-helical structure. 
Addition of 3 M urea to different concentrations of TFE 
also had the same effect on secondary structure, although 
the magnitude of stabilization was lesser at lower TFE 
concentrations (Fig.  6b). CD spectra of hGH incubated 
in presence of 8  M urea showed no effect on the sec-
ondary structure indicating resistance of hGH towards 
denaturation by urea. CD spectra of hGH in presence of 
6 M GdnHCl on the other hand, showed complete loss of 
helicity indicating complete loss of secondary structure. 
TFE based buffer thus protects the secondary structure 
of protein in the solubilized state. 
Size exclusion chromatography of solubilized hGH
SEC is routinely used to characterize the hydrodynamic 
radii and molecular weight of globular proteins. SEC is a 
separation based technique and works on the principle 
that larger sized particles elute first, followed by smaller 
sized particles. It is a better method to characterize the 
tertiary structure of globular proteins as it gives informa-
tion based on global structure unlike fluorescence based 
techniques that gives information about the environ-
ment of the fluorophore (tryptophan or tyrosine) only. 
SEC was used to find out the effect of TFE based buffer 
on the hydrodynamic radii of hGH. Hydrodynamic radii 
of hGH in presence of TFE based buffer was compared 
to that in presence of Tris–HCl buffer. Figure 6c shows 
that hGH in presence of Tris–HCl buffer elutes at about 
21  min and in presence of TFE based buffer elutes at 
about 16  min. This shows that hGH is properly folded 
and has a compact structure in presence of Tris–HCl 
buffer with a smaller hydrodynamic radii, while in pres-
ence of TFE based buffer, the protein loses its compact 
structure and its hydrodynamic radii increases. This sug-
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Fig. 5 Expression of IBs of different proteins and their solubilization by TFE based buffer. a Expression of IBs of different proteins. Lane 1–9 is hGH, 
enolase, asparaginase, polyketide synthase, aldolase, ovalbumin, superoxide dismutase, ovine growth hormone and lysozyme IBs respectively, lane 
M LMW marker (97, 66, 45, 30, 20.1 and 14.5 kDa). b SDS-PAGE analysis of IB solubilization by TFE based buffer. Lane 1–9 are supernatant of hGH, 
enolase, asparaginase, polyketide synthase, aldolase, ovalbumin, superoxide dismutase, ovine growth hormone and lysozyme IBs solubilized in TFE 
based buffer respectively, lane M LMW marker (97, 66, 45, 30, 20.1 and 14.5 kDa)
Table 4 Composition of solubilization buffers used for CD 
spectroscopy
Buffer Buffer composition
a 10 mM Tris–HCl, pH 8.5
b 8 M urea, 10 mM Tris–HCl, pH 8.5
c 6 M GdnHCl, 10 mM Tris–HCl, pH 8.5
d 0–50 % TFE, 10 mM Tris–HCl, pH 8.5
e 0–50 % TFE, 3 M urea, 10 mM Tris–HCl, pH 8.5
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Fluorescence spectroscopy of solubilized hGH
The tertiary structure of hGH in presence of TFE based 
buffer was analyzed by fluorescence spectroscopy and 
was compared to that in presence of other solubilization 
buffers (Table 5). hGH contains one tryptophan and eight 
tyrosine residues, which makes it a very good model for 
fluorescence studies. Selective information about the 
environment of tryptophan can be obtained by excit-
ing at 295 nm, where tyrosine residues do not absorb. In 
case of hGH, excitation of both tyrosine and tryptophan 
residues at 280 nm is beneficial, as it helps in discriminat-
ing native state from partially folded and unfolded states. 
In the folded state the tyrosine residues are in vicinity 
of tryptophan and due to energy transfer from tyrosine 
to tryptophan, tyrosine emission is not observed and 
only a single peak of tryptophan emission is observed 
at 337 nm, which shows that tryptophan is buried in the 
hydrophobic core. In the denatured state though, tyros-
ine residues are separated from tryptophan residue and 
tyrosine emission at 305 nm is observed due to failure of 
energy transfer and a red shift in tryptophan emission is 
seen at 357 nm [24, 26].
Figure 6d shows fluorescence spectra of hGH in pres-
ence of Tris–HCl buffer (native protein) and in 6 M Gdn-
HCl (denatured protein). In presence of 8 M urea, hGH 
spectrum looks similar to that of native protein, with a 
slight red shift to 342 nm. This shows that hGH is resist-
ant to denaturation by urea. In presence of TFE based 
buffers, hGH spectrum looked like that of denatured pro-
tein in presence of 6 M GdnHCl. Two separate peaks, one 
for tyrosine emission at 300 nm and other for tryptophan 
emission at 352 nm were observed. Tryptophan emission 
was slightly blue shifted as compared to that in presence 
of GdnHCl that points to the possibility that hGH struc-
ture in presence of TFE based buffers is not that opened 
up as in case of 6 M GdnHCl. Another possibility is that 
hGH structure in TFE based buffers is as opened up as in 
case of 6 M GdnHCl and the slight blue shift of 5 nm in 
case of TFE based buffers could be due to solvent effects, 
as polarity of TFE is lesser as compared to water. To find 
out the effect of solvent polarity on emission maxima, 
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Fig. 6 Analysis of secondary and tertiary structure of hGH in solubilized state. a Far UV CD spectra of hGH in 8 M urea, 6 M GdnHCl and varying con-
centrations of TFE. b Far UV CD spectra of hGH in 8 M urea, 6 M GdnHCl and varying concentrations of TFE in presence of 3 M urea. c Size exclusion 
chromatogram of hGH incubated in Tris–HCl and 50 % TFE. d Fluorescence spectra of hGH incubated in different buffers. e Normalized fluorescence 
spectra of NATA incubated in different buffers. f Stern–Volmer plots for acrylamide quenching of hGH in presence of different buffers
Table 5 Composition of  buffers used for  fluorescence 
spectroscopy
Buffer Buffer composition
a 50 mM Tris–HCl, pH 8.5
b 8 M urea, 50 mM Tris–HCl, pH 8.5
c 6 M GdnHCl, 50 mM Tris–HCl, pH 8.5
d 50 % TFE, 50 mM Tris–HCl, pH 8.5
e 50 % TFE, 3 M urea, 50 mM Tris–HCl, pH 8.5
Page 9 of 13Upadhyay et al. Microb Cell Fact  (2016) 15:100 
fluorescence properties of tryptophan analogue, NATA 
were studied in presence of different buffers (Table  6). 
Figure 6e shows NATA fluorescence in different buffers. 
Emission maxima of NATA in presence of TFE based 
buffers were slightly blue shifted as compared to that in 
presence of Tris–HCl and 6  M GdnHCl. This suggests 
that the protein tertiary structure in presence of TFE 
based buffers is as denatured as in case of 6 M GdnHCl.
Tryptophan accessibility of hGH in different solubilization 
buffers by acrylamide quenching
To further understand the effect of TFE based buffers on 
structure of hGH, acrylamide quenching studies were 
carried out. Acrylamide is a collisional quencher and 
decreases the fluorescence intensity by interacting with 
the fluorophore and promoting non-radiative transfer to 
the ground state. Acrylamide quenching is used to find 
out the accessibility of tryptophan in a protein molecule. 
If tryptophan residue is buried in the hydrophobic core of 
a compactly folded protein molecule, increasing concen-
trations of acrylamide, do not bring out a big decrease in 
the fluorescence intensity. On the other hand, if a trypto-
phan residue is surface exposed or in denatured protein, 
where tryptophan is solvent exposed, increasing concen-
trations of acrylamide substantially decrease the fluores-
cence intensity. The decrease in fluorescence intensity 
with quencher concentration is related with a mathemat-
ical equation known as Stern–Volmer equation (Eq. 1).
In this study, hGH was incubated in presence of dif-
ferent buffers (Table  7) and tryptophan accessibility 
in each case was measured using acrylamide quench-
ing. Figure  6f shows Stern–Volmer plots obtained after 
acrylamide quenching experiments with hGH incubated 
in five different buffers. Table  8 shows Stern–Volmer 
quenching constants obtained after fitting the data in 
Eq. 1. It was concluded from Fig. 6f and Table 8 that hGH 
incubated in Tris–HCl buffer shows minimum change in 
fluorescence intensity and has least value of Stern–Vol-
mer quenching constant (0.19 ×  10−2). This shows that 
tryptophan is shielded from the solvent and has least 
accessibility in Tris–HCl buffer. Maximum accessibil-
ity of tryptophan can be seen in case of GdnHCl buffer 
with Stern–Volmer quenching constant of 1.66 ×  10−2. 
This is expected as it is widely reported that 6 M GdnHCl 
completely denatures hGH. hGH is known to be resist-
ant to denaturation by urea. Stern–Volmer quenching 
constant obtained in case of urea reflects that with a 
value of 0.44 × 10−2. Stern–Volmer quenching constants 
obtained in case of TFE based buffers have values slightly 
lesser than that observed with GdnHCl. This points to 
the possibility that hGH is not completely denatured by 
TFE based buffers. But as already seen in case of intrinsic 
tryptophan fluorescence experiments, this could also be 
due to the solvent effects i.e. decreased polarity of TFE 
in comparison to water. In Fact, TFE, because of pres-
ence of halogen groups act as a quencher and NATA 
fluorescence in presence of TFE based buffers is lesser as 
compared to that in presence of Tris buffer, pH 8.5 (Addi-
tional file  1: Figure S1a). Acrylamide quenching experi-
ment with NATA also shows lesser slope with TFE based 
buffers than GdnHCl and Tris buffer (Additional file  1: 
Figure S1b).
Conclusions
This study establishes the effectiveness of TFE based 
solubilization agent for recovery of hGH from IBs with 
improved yield as compared to urea based solubiliza-
tion agents. The overall yield of purified recombinant 
hGH using TFE based solubilization method is similar to 
already described solubilization methods using high pH 
buffer and n-propanol based buffer. It was also observed 
that TFE acts as a mild but effective solubilization agent 
by stabilizing secondary structures and destabilizing ter-
tiary structures. None of the solubilization agents known 
Table 6 Composition of  buffers used for  NATA fluores-
cence
Buffer Buffer composition
a 50 mM Tris–HCl, pH 8.5
b 6 M GdnHCl, 50 mM Tris–HCl, pH 8.5
c 50 % TFE, 50 mM Tris–HCl, pH 8.5
d 50 % TFE, 3 M urea, 50 mM Tris–HCl, pH 8.5
Table 7 Composition of  buffers used for  acrylamide 
quenching experiments
Buffer Buffer composition
a 50 mM Tris–HCl, pH 8.5
b 8 M urea, 50 mM Tris–HCl, pH 8.5
c 6 M GdnHCl, 50 mM Tris–HCl, pH 8.5
d 50 % TFE, 50 mM Tris–HCl, pH 8.5
e 50 % TFE, 3 M urea, 50 mM Tris–HCl, pH 8.5
Table 8 Stern–Volmer quenching constants for acrylamide 
quenching of hGH incubated in different buffers
Buffer Stern–Volmer quenching constant
a 0.19 × 10−2
b 0.47 × 10−2
c 1.66 × 10−2
d 1.06 × 10−2
e 1.22 × 10−2
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act as universal solubilization agent. Screening of solubili-
zation agents for every protein is thus necessary for find-
ing efficient ways for recovering active protein from IBs 
[27]. As TFE is known to induce secondary structures in 
proteins, mainly alpha helices, it could be really helpful 
in solubilization of proteins that adopt an alpha helix rich 
native state. As most of the IB proteins have native-like 
secondary structure, it is expected that solubilization with 
TFE will protect the existing native-like secondary struc-
ture and thus will enhance the recovery of bioactive pro-
tein from solubilized state. Ability of TFE to solubilize a 
number of IB proteins encourage its use as solubilization 
agent for IB proteins that cannot be recovered by conven-
tional methods. This study also encourages screening of 
different organic solvents for solubilization of IB aggre-
gates for high throughput recovery of bioactive protein.
Methods
Chemicals and reagents
Components for culture media, tryptone and yeast 
extract were purchased from Difco Laboratories, India. 
Glycine, phenylmethylsulfonyl fluoride (PMSF), isopro-
pyl β-d-1-thiogalactopyranoside (IPTG), Tris buffer and 
sodium dodecyl sulphate (SDS) were from Amresco, 
USA. Glucose and NaCl were purchased from Qualigen, 
India. Low molecular weight marker for SDS-PAGE and 
DEAE-Sepharose Fast Flow media were from GE Health-
care, USA. Dithiothreitol (DTT), acrylamide, bis-acryla-
mide, urea, ammonium persulphate (APS), TFE, NATA 
and ovalbumin were purchased from Sigma-Aldrich, 
USA. Bromophenol blue, Tetramethylethylenediamine 
(TEMED) and Ethylenediaminetetraacetic acid (EDTA) 
were procured from BIO-RAD, USA. Micro BCA assay 
kit was purchased from Pierce, USA.
Expression of recombinant proteins and IB preparation
Escherichia coli BL21 (DE3) or M15 (pREP4) cells were 
transformed with different vectors encoding recombinant 
proteins (hGH, enolase, asparaginase, polyketide syn-
thase, aldolase, ovalbumin, superoxide dismutase, ovine 
growth hormone and lysozyme) [28, 29]. Table  9 shows 
details of recombinant protein clones in E. coli. The 
transformed cells were cultured overnight in LB agar 
plates supplemented with ampicillin and kanamycin at 
37  °C. Single colonies were picked and grown overnight 
in modified LB broth containing 5  g/l glucose (37  °C, 
200 rpm) supplemented with either 100 μg/ml ampicillin 
or 100 μg/ml ampicillin and 25 μg/ml kanamycin depend-
ing on the construct. The overnight grown cultures were 
diluted with fresh modified LB broth containing antibiot-
ics and allowed to grow until OD600 reached 0.5. The cul-
ture was then induced with 1 mM IPTG and allowed to 
grow for 3 h. The cells were harvested by centrifugation 
and checked for expression of hGH by SDS-PAGE.
The E. coli cell pellet obtained from 1  l culture was 
resuspended in 20  ml of 50  mM Tris–HCl, pH 8.5, 
100 mM NaCl, 1 mM PMSF and 5 mM EDTA and soni-
cated on ice at amplitude of 50 for 10 cycles with 1 min 
gap between each cycle. Each cycle of 1 min comprised of 
alternate on and off pulses of 1 s (Q 700 sonicator, Qson-
ica, USA). The lysed bacterial suspension was centri-
fuged at 15,000g for 20 min at 4 °C (Sorvall RC 6+, USA). 
The pellet obtained was washed by resuspending in MQ 
water and centrifuging at 15,000g for 20 min at 4 °C. The 
washing process was repeated twice. The washed IBs 
were finally resuspended in 4 ml of MQ water.
Solubilization of IBs and refolding of solubilized protein
The IBs obtained were solubilized in different concen-
trations of TFE ranging from 5 to 50 % in order to check 
its solubilization potential. Ten microlitre of IB suspen-
sion was incubated in 90  μl buffers containing 50  mM 
Tris–HCl, pH 8.5 and varying concentrations of TFE 
(5–50  %) at room temperature for 2  h. The turbidity of 
the samples was then monitored at 350 nm to determine 
the solubilization potential. Similarly, the solubilization 
Table 9 Details of recombinant proteins expressed as inclusion bodies
Protein Expression host Expression vector Antibiotic selection pressure
Human growth hormone E. coli M15 (pREP) pQE 60 Ampicillin, kanamycin
Enolase E. coli BL21 (DE3) pET 22b Ampicillin
Asparaginase E. coli BL21 (DE3) pET 14b Ampicillin
Polyketide synthase E. coli BL21 (DE3) pET 22b Ampicillin
Aldolase E. coli BL21 (DE3) pET 22b Ampicillin
Ovalbumin E. coli BL21 (DE3) pET 3d Ampicillin
Superoxide dismutase E. coli M15 (pREP) pQE 60 Ampicillin, kanamycin
Ovine growth hormone E. coli M15 (pREP) pQE 60 Ampicillin, kanamycin
Lysozyme E. coli BL21 (DE3) pET 21c Ampicillin
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potential of buffers containing different concentrations of 
TFE (5–50 %) along with low concentration of urea (3 M) 
was also determined. Solubilization potential of different 
buffers was also checked by SDS-PAGE. The solubilized 
samples (20–50 % TFE and 10–40 % TFE with 3 M urea) 
were centrifuged at 15,000g for 10  min at 25  °C. Equal 
volume (10 μl) of supernatant was loaded on SDS-PAGE 
to compare solubilization potential of various solubiliza-
tion buffers.
The IBs obtained from 1  l of bacterial culture were 
solubilized in 25  ml of solubilization buffer containing 
50 mM Tris–HCl, pH 8.5, 3 M urea, 30 % TFE and 1 mM 
DTT. The suspension was incubated at room tempera-
ture for 2 h and then centrifuged at 15,000g for 30 min. 
The supernatant was added into 250  ml of refolding 
buffer containing 50 mM Tris–HCl, pH 8.5. The refolded 
sample was centrifuged at 24,000g for 30 min at 4  °C to 
obtain the supernatant. Protein concentration in super-
natant, measured by BCA method, was compared to that 
in solubilized sample to calculate the refolding yield. The 
supernatant was then used for chromatographic purifica-
tion. For comparison, IBs obtained from 1 l bacterial cul-
ture were also solubilized in 25 ml of solubilization buffer 
containing 50 mM Tris–HCl, pH 8.5, 8 M urea and 1 mM 
DTT. The suspension was processed in the same manner 
as mentioned above to obtain refolded protein and for 
calculation of refolding yield.
Purification of hGH
Refolded hGH was purified using ion exchange and SEC. 
DEAE-Sepharose Fast Flow media (40  ml) was packed 
in XK-26/40 column (Pharmacia, Sweden). Column was 
washed with 250  ml MQ water and equilibrated with 
200  ml of equilibration buffer (50  mM Tris, pH 8.5). 
Refolded r-hGH (250 ml) was loaded onto DEAE-Sepha-
rose column and washed with 150  ml of equilibration 
buffer. Elution was carried out using a gradient of NaCl 
ranging from 0 to 500  mM. Equilibration, protein load-
ing, washing and elution were performed at a flow rate of 
5 ml/min. Homogeneity of eluted protein was checked by 
SDS-PAGE.
Eluates containing hGH were pooled and dialyzed 
against 50  mM Tris–HCl, pH 8.5. Dialyzed sample was 
concentrated to 2  ml using Amicon Ultra centrifugal 
concentrator (Millipore, USA) with molecular weight 
cutoff 3  kDa. Concentrated sample was centrifuged at 
15,000g, 4  °C for 10  min. Two ml of concentrated sam-
ple was loaded for SEC onto HiLoad 16/600 Superdex 
200 PG column (GE healthcare, UK) pre-equilibrated 
with 250 ml of 50 mM Tris–HCl, pH 8.5 at a flow rate of 
1 ml/min. Homogeneity of eluted protein was checked by 
SDS-PAGE. The molar extinction coefficient of hGH was 
taken as 18,890/M/cm as reported earlier [30] and was 
used to calculate the concentration of pure hGH. Protein 
concentration of the IBs, solubilized protein and refolded 
protein was determined by BCA assay kit (Pierce, USA) 
using BSA as standard.
Fluorescence and circular dichroism (CD) spectroscopy 
of recombinant hGH
Fluorescence emission spectra of purified recombinant 
hGH were recorded using the Cary Eclipse spectrofluor-
imeter (Varian, USA). 50 µg/ml solution of purified hGH 
in buffer containing 50 mM Tris–HCl, pH 8.5 was excited 
at 280 nm and emission spectra were collected from 290 
to 400 nm with excitation and emission slit width set at 
5 nm. Far UV circular dichroism (CD) spectra of purified 
recombinant hGH were recorded using Jasco-700 spec-
tro-polarimeter in the wavelength range of 200–250 nm 
at 25  °C. A 200  µg/ml solution of purified recombinant 
hGH in buffer containing 20 mM Tris–HCl, pH 8.5 was 
taken in 1  mm path length cuvette. Near UV CD spec-
tra of purified protein were recorded in the wavelength 
range 250–300 nm at 25 °C. One mg/ml solution of puri-
fied hGH in the aforementioned buffer was taken in 
10 mm pathlength cuvette. Each spectrum was scanned 
three times and the average spectrum was plotted.
Cell proliferation assay using Nb2 cells
Nb2 cell line was maintained in RPMI medium contain-
ing 10 % FCS and 10 % HS. The cells were arrested in G0/
G1 phase by incubating in RPMI medium in presence of 
1  % FCS and 10  % HS. The cell proliferation assay was 
performed in a flat bottom 96 well plate. Commercial 
hGH (Boehringer Mannheim, Germany) was used as 
positive control [17]. An unrelated protein, ovalbumin 
was taken as negative control. The cellular proliferation 
was checked by counting the number of cells at definite 
intervals after incubating the cells in presence of 5 ng/ml 
of purified hGH. Statistical significance of the results was 
analyzed by unpaired t test (p  <  0.05) in the GraphPad 
Prism software version 6.
Far UV CD spectroscopy of hGH in solubilized state
Far UV CD spectra of hGH were recorded using Jasco-
700 spectro-polarimeter in the wavelength range of 
200–250 nm at 25 °C. 200 µg/ml solution of purified hGH 
incubated in different buffers (Table 4) for 6 h were taken 
in 1 mm path length cuvette. An average of three inde-
pendent spectra acquired for each sample was used for 
analysis.
Size exclusion chromatography of hGH in solubilized state
In this study, hGH was incubated in either 50 mM Tris–
HCl, pH 8.5 or 50  mM Tris–HCl, pH 8.5 containing 
50  % TFE. 10  µl of hGH samples incubated in different 
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buffers were loaded onto the TSKgel G3000SWXL col-
umn (Tosoh, Japan) with internal diameter 4.6  mm and 
length 30  cm pre equilibrated with 50  ml of respective 
buffers at a flow rate of 0.5  ml/min. Elution profile of 
protein was followed by monitoring UV absorbance at 
280 nm on Shimadzu UFLC system with CBM-20A sys-
tem controller.
Fluorescence spectroscopy of hGH in solubilized state
Fluorescence emission spectra were recorded using the 
Cary Eclipse spectrofluorimeter (Varian, USA). 100  µg/
ml solution of purified hGH or 5 µM solution of NATA 
incubated in different buffers (Tables  5, 6) for 6  h were 
excited at 280  nm and emission spectra were collected 
from 290 to 400 or 300 to 440  nm with excitation and 
emission slit width set at 5 nm. An average of three inde-
pendent spectra acquired for each sample was used for 
analysis.
Tryptophan accessibility of hGH in different solubilization 
buffers by acrylamide quenching
For this experiment purified hGH and NATA were incu-
bated in different buffers (Table 7) for 6 h at room tem-
perature. Final concentration of hGH used was 200  µg/
ml. 1 ml of hGH solution in respective buffer was taken 
in a 10  ×  4  mm cuvette and 5  M acrylamide solution 
was added to achieve acrylamide concentrations ranging 
from 0 to 120 mM. Samples were incubated for 30 min. 
Samples were then excited at 295 nm and emission spec-
tra were acquired in the range of 300–400 nm. Excitation 
and emission slit width were set at 5 nm. Each spectrum 
was scanned three times and the average spectrum was 
plotted. Stern–Volmer plots were generated by plotting 
relative fluorescence intensities against acryamide con-
centrations and data were fitted into Stern–Volmer equa-
tion (Eq. 1) to obtain Stern–Volmer quenching constants.
F0 is steady state fluorescence intensity in absence of 
quencher, F is steady state fluorescence intensity in pres-
ence of quencher, Q is quencher concentration and K is 
Stern–Volmer quenching constant which is a measure of 
exposure of the fluorophore to the solvent.
(1)F0/F = 1+ K[Q]
Additional file
Additional file 1: Figure S1. Analysis of NATA fluorescence and acryla-
mide quenching of NATA. a) Fluorescence spectra of NATA incubated in 
different buffers. b) Stern–Volmer plots for acrylamide quenching of NATA 
in presence of different buffers.
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